CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-02 | Tennant Stanley Director | Grant or award · Restricted Stock Units | +16,667 | 16,667 | ||
| 2017-01-02 | WELCH WILLIAM J CEO | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2017-01-02 | ADAMS THOMAS PHD Director | Grant or award · Restricted Stock Units | +16,667 | 16,667 | ||
| 2017-01-02 | Erlander Mark Chief Scientific Officer | Exercise or conversion | +50,000 | 55,000 | ||
| 2017-01-02 | Erlander Mark Chief Scientific Officer | Shares withheld for taxes | −23,968 | 31,032 | ||
| 2017-01-02 | Erlander Mark Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −50,000 | 0 | ||
| 2017-01-02 | Erlander Mark Chief Scientific Officer | Grant or award · Restricted Stock Units | +30,001 | 30,001 | ||
| 2017-01-02 | Erlander Mark Chief Scientific Officer | Grant or award · Restricted Stock Units | +75,000 | 105,001 | ||
| 2017-01-02 | Billings Paul Director | Grant or award · Restricted Stock Units | +16,667 | 16,667 | ||
| 2017-01-02 | JACOB GARY S Director | Grant or award · Restricted Stock Units | +16,667 | 16,667 | ||
| 2017-01-02 | BRANCACCIO JOHN P Director | Grant or award · Restricted Stock Units | +16,667 | 16,667 | ||
| 2017-01-02 | Markin Rodney S Director | Grant or award · Restricted Stock Units | +16,667 | 16,667 | ||
| 2016-12-19 | Tennant Stanley Director | Purchase | +10,000 | $2.10 | $21K | 217,728 |
| 2016-12-16 | WELCH WILLIAM J CEO | Purchase | +2,500 | $2.10 | $5K | 2,500 |
| 2016-12-16 | WELCH WILLIAM J CEO | Purchase | +2,250 | $2.09 | $5K | 4,750 |
| 2016-12-16 | Tennant Stanley Director | Purchase | +14,966 | $2.00 | $30K | 207,728 |
| 2016-12-14 | Erlander Mark Chief Scientific Officer | Purchase | +5,000 | $2.08 | $10K | 5,000 |
| 2016-11-11 | BRIDGER MANAGEMENT, LLC Former 10% Owner | Purchase | −322,472 | $3.08 | $993K | 2,968,115 |
| 2016-05-02 | Erlander Mark Chief Scientific Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 |
Page 15 of 15 · 299 trades